These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Sequential therapy with methotrexate and 5-fluorouracil in the treatment of advanced colorectal carcinoma. Leone BA; Romero A; Rabinovich MG; Perez JE; Macchiavelli M; Strauss E J Clin Oncol; 1986 Jan; 4(1):23-7. PubMed ID: 3941331 [TBL] [Abstract][Full Text] [Related]
45. Sequential 5-fluorouracil, methotrexate, and calcium leucovorin in metastatic colorectal cancer. Hansen RM; Banerjee TK; Davis HL; Zaentz SD; Schiferl EA; Ousley JL; Pogodzinski AE; Trump DL Wis Med J; 1988 May; 87(5):20-3. PubMed ID: 3291405 [No Abstract] [Full Text] [Related]
46. MACC (methotrexate, adriamycin, cyclophosphamide and CCNU) in advanced lung cancer. Chahinian AP; Mandel EM; Holland JF; Jaffrey IS; Teirstein AS Cancer; 1979 May; 43(5):1590-7. PubMed ID: 221093 [No Abstract] [Full Text] [Related]
47. Combination of constant-infusion 5-fluorouracil, methyl-CCNU, mitomycin C, and vincristine in advanced colorectal carcinoma. Greco FA; Richardson RL; Shulman SF; Oldham RK Cancer Treat Rep; 1978 Sep; 62(9):1407-8. PubMed ID: 688289 [No Abstract] [Full Text] [Related]
48. Sequential methotrexate plus 5-FU in advanced breast and colorectal cancers: a phase II study. Kaye SB; Sangster G; Hutcheon A; Habeshaw T; Crossling F; Ferguson C; McArdle C; Smith D; George WD; Calman KC Cancer Treat Rep; 1984 Mar; 68(3):547-8. PubMed ID: 6704984 [TBL] [Abstract][Full Text] [Related]
49. Cyclophosphamide versus cyclophosphamide, methotrexate, and 5-fluorouracil in advanced prostatic cancer: a randomized trial. Muss HB; Howard V; Richards F; White DR; Jackson DV; Cooper MR; Stuart JJ; Resnick MI; Brodkin R; Spurr CL Cancer; 1981 Apr; 47(8):1949-53. PubMed ID: 7194733 [TBL] [Abstract][Full Text] [Related]
50. Sequential methotrexate and 5-FU in the treatment of colorectal cancer. Weinerman B; Schacter B; Schipper H; Bowman D; Levitt M Cancer Treat Rep; 1982 Jul; 66(7):1553-5. PubMed ID: 6980048 [TBL] [Abstract][Full Text] [Related]
51. Chemotherapy for bronchogenic carcinoma. Methotrexate, doxorubicin, cyclophosphamide, and lomustine. Chahinian PA; Arnold DJ; Cohen JM; Purpora DP; Jaffrey IS; Teirstein AS; Kirschner PA; Holland JF JAMA; 1977 May; 237(22):2392-6. PubMed ID: 576939 [TBL] [Abstract][Full Text] [Related]
52. Sequential phase II studies of chemotherapy for colorectal cancer with 5-fluorouracil and vindesine with or without methyl-1,3 cis(2 chloroethyl)-1-nitrosourea. Stroehlein JR; Bedikian AY; Karlin DA; Valdivieso M; Bennetts RW; Bodey GP Am J Clin Oncol; 1982 Aug; 5(4):421-7. PubMed ID: 7113964 [TBL] [Abstract][Full Text] [Related]
53. Low dose chemotherapy of metastatic breast cancer with cyclophosphamide, adriamycin, methotrexate, 5-fluorouracil (CAMF) versus sequential cyclophosphamide, methotrexate, 5-fluorouracil (CMF) and adriamycin. Creech RH; Catalano RB; Harris DT; Engstrom PF; Grotzinger PJ Cancer; 1979 Jan; 43(1):51-9. PubMed ID: 367574 [TBL] [Abstract][Full Text] [Related]
54. Prospective randomized reappraisal of 5-fluorouracil in metastatic colorectal carcinoma. A comparative trial with 6-thioguanine. Presant CA; Denes AE; Liu C; Bartolucci AA Cancer; 1984 Jun; 53(12):2610-4. PubMed ID: 6372981 [TBL] [Abstract][Full Text] [Related]
55. Methyl-CCNU and methotrexate therapy in patients with advanced colorectal cancer after failure of 5-fluorouracil chemotherapy. Zorzitto ML; Myers R; Bazos MJ; Shepherd FA; Evans WK Am J Clin Oncol; 1986 Feb; 9(1):27-30. PubMed ID: 3953490 [TBL] [Abstract][Full Text] [Related]
56. Combination chemotherapy of colorectal cancer with 5-fluorouracil, methyl-1,3-cis(2-chloroethyl)-1-nitrosourea, and vincristine. Joss RA; Goldberg RS; Yates JW Med Pediatr Oncol; 1979; 7(3):251-5. PubMed ID: 542190 [TBL] [Abstract][Full Text] [Related]
57. A Northern California Oncology Group randomized trial of leucovorin plus 5-fluorouracil versus sequential methotrexate, 5-fluorouracil, and leucovorin in patients with advanced colorectal cancer who failed treatment with 5-fluorouracil or 5-fluorodeoxyuridine alone. Valone FH; Kohler M; Fisher K; Hannigan J; Flam M; Gandara D; Hendrickson C; Richman E; Yu KP NCI Monogr; 1987; (5):175-7. PubMed ID: 2963230 [TBL] [Abstract][Full Text] [Related]
58. Randomized study of continuous infusion fluorouracil versus fluorouracil plus cisplatin in patients with metastatic colorectal cancer. Kemeny N; Israel K; Niedzwiecki D; Chapman D; Botet J; Minsky B; Vinciguerra V; Rosenbluth R; Bosselli B; Cochran C J Clin Oncol; 1990 Feb; 8(2):313-8. PubMed ID: 2405107 [TBL] [Abstract][Full Text] [Related]
59. Phase II study of sequential methotrexate-5-FU therapy in advanced measurable colorectal cancer. Cantrell JE; Brunet R; Lagarde C; Schein PS; Smith FP Cancer Treat Rep; 1982 Jul; 66(7):1563-5. PubMed ID: 7093972 [TBL] [Abstract][Full Text] [Related]
60. Advanced ovarian carcinoma: a prospective and randomized clinical trial of cyclophosphamide versus combination cytotoxic chemotherapy (Hexa-CAF). Carmo-Pereira J; Costa FO; Henriques E; Ricardo JA Cancer; 1981 Nov; 48(9):1947-51. PubMed ID: 6271386 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]